Access brought to you by: LOCKSS
Login
Multiple Sclerosis Patients Who Switch DMDs Can Reduce Clinical Activity
DMD, disease-modifying drug.
Rio J et al. Change in the clinical activity of multiple sclerosis after treatment switch for suboptimal response. Eur J Neurol. 2012;19:899–904.
Impact of DMD Exposure on Second Multiple Sclerosis Attack
CIS, clinically isolated syndrome; DMD, disease-modifying drug.
Reproduced with permission from T Spelman, MD.
Thank you for your interest in spreading the word on MD Conference Express.
NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.